ApprovalTrail

Drug · DIN 00505005

FLUORESCITE

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since May 30, 2019; first marketed December 31, 1980.
Drug Identification Number (DIN)
00505005
Company (DIN owner)
Alcon Canada Inc.Mississauga, Ontario, Canada
Schedule
Ethical
Dosage form
Solution
Route
Intravenous
Therapeutic class (ATC)
Other diagnostic agents V04CX
Class
Human
Record last updated
December 16, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
FLUORESCEIN (FLUORESCEIN SODIUM)10 %W/V